The global Neuroendovascular Non-coils Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Neuroendovascular stents, Access devices, Flow diversion devices, Others), By End-User (Hospitals, Ambulatory surgical centers, Stroke centers, Others).
The neuroendovascular non-coils market in 2025 is witnessing rapid growth driven by the increasing adoption of neurovascular stents, flow diverters, and embolic agents in the endovascular treatment of cerebrovascular diseases such as intracranial aneurysms, ischemic strokes, and arteriovenous malformations (AVMs). Neuroendovascular non-coil devices play a critical role in providing structural support, flow redirection, and occlusion of intracranial vessels, enabling minimally invasive treatment options and improved outcomes for patients with complex neurovascular conditions. With advancements in device design, material technology, and procedural techniques, neuroendovascular non-coil devices offer enhanced safety, efficacy, and long-term durability in endovascular interventions. Market players are investing in product innovation, clinical research, and physician training programs to expand the applications and improve the performance of neuroendovascular non-coil devices, driving further adoption and market growth in this segment.
The global Neuroendovascular Non-coils Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Neuroendovascular Non-coils Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Neuroendovascular Non-coils Industry include- BALT Group, Johnson and Johnson, Kaneka Corp, Medtronic Plc, Penumbra Inc, Rapid Medical Ltd, Shape Memory Medical Inc, Stryker Corp, Terumo Corp, WallBy Medical LLC.
In the Neuroendovascular Non-coils market, a prominent trend is the expansion of neurointerventional devices beyond coils. While coils have been a cornerstone in endovascular treatment for cerebral aneurysms, there's a growing demand for alternative devices to address a broader range of neurovascular conditions. Non-coil devices such as flow diverters, stents, and liquid embolics are gaining prominence for their ability to treat complex aneurysms, arteriovenous malformations (AVMs), and intracranial stenosis. This trend reflects a shift towards a more comprehensive and versatile approach to neuroendovascular interventions, offering neurointerventionalists a wider array of tools to tailor treatment strategies to individual patient needs.
The primary market driver for Neuroendovascular Non-coils is the advancements in minimally invasive neurointerventional techniques. With the advent of innovative devices and imaging technologies, neurointerventional procedures have become safer, more precise, and less invasive, driving the adoption of non-coil devices in the treatment of neurovascular diseases. Non-coil devices offer advantages such as improved navigability, enhanced flow diversion, and reduced risk of thromboembolic complications, contributing to better patient outcomes and shorter recovery times. As neurointerventionalists continue to refine their skills and expand their procedural capabilities, the demand for non-coil devices is expected to grow.
An emerging opportunity in the Neuroendovascular Non-coils market lies in the development of personalized treatment approaches with combinatorial devices. Combining different non-coil devices such as flow diverters, stents, and embolic agents allows neurointerventionalists to tailor treatment strategies to the specific anatomical and hemodynamic characteristics of each patient's neurovascular pathology. Personalized approaches aim to optimize treatment efficacy while minimizing procedural risks and long-term complications, offering a potential avenue for innovation and differentiation in the market. Collaborative research efforts and clinical trials exploring the synergistic effects of combinatorial devices present an opportunity for manufacturers to address unmet clinical needs and improve patient outcomes in neuroendovascular therapy.
Neuroendovascular stents emerge as the fast-growing segment within the category of neuroendovascular non-coils. These stents play a crucial role in the treatment of various neurovascular conditions, including intracranial stenosis and aneurysm coiling. Designed to provide structural support and maintain vessel patency, neuroendovascular stents are witnessing a surge in demand due to advancements in minimally invasive endovascular procedures. The increased adoption of neuroendovascular stents can be attributed to their effectiveness in restoring blood flow, reducing the risk of revascularization, and improving patient outcomes. Additionally, ongoing technological innovations, such as the development of drug-eluting and flow-diverting stents, further contribute to the rapid growth of this segment. With hospitals, ambulatory surgical centers, and stroke centers increasingly incorporating neuroendovascular stents into their treatment protocols, this segment is poised for significant expansion in the neuroendovascular market.
By Product
By End-User
Geographical Analysis
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Neuroendovascular Non-coils Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Neuroendovascular Non-coils Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Neuroendovascular Non-coils Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Neuroendovascular Non-coils Market Size Outlook, $ Million, 2021 to 2030
3.2 Neuroendovascular Non-coils Market Outlook by Type, $ Million, 2021 to 2030
3.3 Neuroendovascular Non-coils Market Outlook by Product, $ Million, 2021 to 2030
3.4 Neuroendovascular Non-coils Market Outlook by Application, $ Million, 2021 to 2030
3.5 Neuroendovascular Non-coils Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Neuroendovascular Non-coils Industry
4.2 Key Market Trends in Neuroendovascular Non-coils Industry
4.3 Potential Opportunities in Neuroendovascular Non-coils Industry
4.4 Key Challenges in Neuroendovascular Non-coils Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Neuroendovascular Non-coils Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Neuroendovascular Non-coils Market Outlook by Segments
7.1 Neuroendovascular Non-coils Market Outlook by Segments, $ Million, 2021- 2030
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
8 North America Neuroendovascular Non-coils Market Analysis and Outlook To 2030
8.1 Introduction to North America Neuroendovascular Non-coils Markets in 2024
8.2 North America Neuroendovascular Non-coils Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Neuroendovascular Non-coils Market size Outlook by Segments, 2021-2030
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
9 Europe Neuroendovascular Non-coils Market Analysis and Outlook To 2030
9.1 Introduction to Europe Neuroendovascular Non-coils Markets in 2024
9.2 Europe Neuroendovascular Non-coils Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Neuroendovascular Non-coils Market Size Outlook by Segments, 2021-2030
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
10 Asia Pacific Neuroendovascular Non-coils Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Neuroendovascular Non-coils Markets in 2024
10.2 Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Neuroendovascular Non-coils Market size Outlook by Segments, 2021-2030
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
11 South America Neuroendovascular Non-coils Market Analysis and Outlook To 2030
11.1 Introduction to South America Neuroendovascular Non-coils Markets in 2024
11.2 South America Neuroendovascular Non-coils Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Neuroendovascular Non-coils Market size Outlook by Segments, 2021-2030
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
12 Middle East and Africa Neuroendovascular Non-coils Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Neuroendovascular Non-coils Markets in 2024
12.2 Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Neuroendovascular Non-coils Market size Outlook by Segments, 2021-2030
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
BALT Group
Johnson and Johnson
Kaneka Corp
Medtronic Plc
Penumbra Inc
Rapid Medical Ltd
Shape Memory Medical Inc
Stryker Corp
Terumo Corp
WallBy Medical LLC
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Neuroendovascular stents
Access devices
Flow diversion devices
Others
By End-User
Hospitals
Ambulatory surgical centers
Stroke centers
Others
The Global Neuroendovascular Non-Coils Market Size is estimated at $1.7 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.8% to reach $2.6 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BALT Group, Johnson and Johnson, Kaneka Corp, Medtronic Plc, Penumbra Inc, Rapid Medical Ltd, Shape Memory Medical Inc, Stryker Corp, Terumo Corp, WallBy Medical LLC
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume